FIRST AMERICAN SCIENTIFIC CORP \NV\
PRE 14A, 2000-03-08
FABRICATED RUBBER PRODUCTS, NEC
Previous: ILEX ONCOLOGY INC, S-3, 2000-03-08
Next: GLOBIX CORP, DEF 14A, 2000-03-08



<PAGE> 1

                       SCHEDULE 14A INFORMATION
     Proxy Statement Pursuant to Section 14(a) of the Securities
                        Exchange Act of 1934.

Filed by the Registrant [ x ]
Filed by Party other than the Registrant [   ]

Check the appropriate box:

[ x ]     Preliminary Proxy Statement
[   ]     Confidential, for Use of the Commission Only [as
          permitted by Rule 14a-6(e)(2)]
[   ]     Definitive Proxy Statement
[   ]     Definitive Additional Materials
[   ]     Soliciting Material Pursuant to Section 240.14a-11(c)
          or Section 240.14a-12

- -----------------------------------------------------------------

                 FIRST AMERICAN SCIENTIFIC CORP.
     (Exact name of Registrant as specified in its charter.)
                  Commission File number 0-27094
- -----------------------------------------------------------------

Payment of Filing Fee (Check the appropriate box):

[ x ]     No fee required.
[   ]     Fee computed on table below per Exchange Act Rule 14a-
          6(I)(4) and O-11.
     1.   Title of each class of securities to which transaction
          applies:
     2.   Aggregate number of securities to which transaction
          applies:
     3.   Per unit price or other underlying value of transaction
          computed pursuant to Exchange Act Rule O-11 (Set forth
          the amount on which the filing fee is calculated and
          state how it was determined):
     4.   Proposed maximum aggregate value of transaction:
     5.   Total fee paid:
[   ]     Fee paid previously with preliminary materials.
[   ]     Check box if any part of the fee is offset as provided
          by Exchange Act Rule O-11(a)(2) and identify the filing
          for which the offsetting fee was paid previously.
          Identify the previous filing by registration statement
          number, or the Form or Schedule and the date of its
          filing.
     1.   Amount Previously Paid:
     2.   Form, Schedule or Registration Statement No.:
     3.   Filing Party:
     4.   Date Filed:

<PAGE> 2
                 FIRST AMERICAN SCIENTIFIC CORP.
        SOLICITATION OF CONSENT OF SHAREHOLDERS STATEMENT

                           INTRODUCTION

     These materials are furnished in connection with the solicitation
by the Board of Directors of First American Scientific Corp., a Nevada
corporation (the "Company"), of consents in writing for one amendment
to the Company's Articles of Incorporation.  Only Shareholders of
record, as of the close of business on March 7, 2000, will be entitled
to tender their written consents to the Company.  This Solicitation of
Consent of Shareholders Statement and form of written consent are being
sent to Shareholders on or about March 20, 2000.

                PURPOSE OF SOLICITATION OF CONSENT

     The Company's Board of Director has passed a resolution calling
for an amendment to the Company's Articles of Incorporation.  The
Company's Board of Directors is soliciting consents in writing to
authorize the proposed amendment which would increase the authorized
Common Stock of the Company from 100,000,000 shares, par value $0.001
per share, to 200,000,000 shares of Common Stock, $0.001 par value per
share.

                 SOLICITATION OF WRITTEN CONSENTS

     These solicitation materials are furnished in connection with the
solicitation of written consents by the Board of Directors and
management of the Company to be used as set forth herein.  Under Nevada
Law, the proposed amendment must be approved by a majority of the
Company's total shares outstanding.

     The Company's Board of Directors has established the close of
business on March 7, 2000, as the record date (the "Record Date") for
determining the shareholders of record.  On March 7, 2000, the Company
had 99,121,018 shares outstanding and entitled to vote.

     If written consents of a majority of the Company's total shares
outstanding as of March 7, 2000, are not received within thirty (30)
days of the date on which the Company first receives the written
consent being solicited hereunder, then such written consents shall be
null and void and the request for written consents of the shareholders
for the approval of the proposed amendment to the Company's Articles of
Incorporation shall be deemed to have failed.  However, if written
consents from a majority of the total shares outstanding (less any such
previously delivered written consents that may have been rescinded by
delivery of a written notice of rescission to the Company) are received
within such thirty (30) day period, then the proposed amendment to the
Company's Articles of Incorporation shall be approved.


<PAGE> 3

     Officers and Directors of the Company are expected to execute
consents in favor of the foregoing action.  Officers and Directors own
1.74% of the outstanding shares the Company's Common Stock.

     The Company does not have any plans to issued additional shares of
common stock at this time.

                  REVOCATION OF WRITTEN CONSENTS

     Any shareholder has the power to revoke his or her written consent
at any time, by the written notice of a subsequently dated written
consent form marked to indicate revocation of the previously granted
written consent, received by the Company prior to the proposed
amendment to the Articles of Incorporation becoming effective.  The
proposed amendment shall become effective at the time, if ever, that
the Company receives written consents from more than 50% of the total
shares of Common Stock outstanding in favor of the proposed changes in
the Company's Articles of Incorporation.

                  SUBMISSION OF WRITTEN CONSENTS

     The Board of Directors of the Company has fixed the close the
business on March 7, 2000, as the record date for determination of the
shareholders of record entitled to notice of, and to submit written
consents in respect of the proposed amendment to the Company's Articles
of Incorporation.  As of the record date there were 99,121,018 shares
of Common Stock entitled to vote.  Written consents representing a
majority of those shares must be received in order to approve the
proposed amendment.

                  INFORMATION CONCERNING VOTING

     As of the close of business on March 7, 2000, the Company has
authorized One hundred Million (100,000,000) shares of one class of
Common Stock and outstanding Ninety-Nine Million, One Hundred
Twenty-one Thousand, Eighteen (99,121,018) shares of one class of
Common Stock.  Only holders of record of the Company's Common Stock at
the close of business on March 7, 2000 are entitled to notice and to
submit written consents as solicited herein.  Proposal No. 1 shall be
decided upon by a majority vote of the total outstanding shares
eligible to vote.









<PAGE> 4

                            PROPOSAL 1

        PROPOSED AMENDMENT TO THE COMPANY'S CERTIFICATE OF
       INCORPORATION TO INCREASE AUTHORIZED COMMON STOCK OF
  THE COMPANY FROM 100,000,000 SHARES $0.001 PAR VALUE PER SHARE
        TO 200,000,000 SHARES, $0.001 PAR VALUE PER SHARE

     The Board of Directors of the Company, on March 1, 2000,
unanimously approved and recommended to the shareholders of the
Company at the special meeting of the Board of Directors, a
proposed amendment to the Company's Certificate of Incorporation
which would increase the Company's authorized shares from
100,000,000 shares of Common Stock, par value $0.001 per share to
200,000,000 shares of Common Stock, par value $0.001 per share.
The proposed amendment would revise the Company's Certificate of
Incorporation to read as follows:

               The total number of shares of Common
          Stock which the Corporation shall have
          authority to issue is Two Hundred Million
          (200,000,000) shares of Common Stock, par
          value $0.001 per share.

     The foregoing amendment to the Articles of Incorporation is
proposed for the reason that the Company has exhausted its
authorized shares of common stock and in order to raise
additional capital from the sale of common stock it must amend
its Articles of Incorporation and increase its authorized
capital.

- ----------------------------------------------------------------

[    ]    The undersigned hereby consents to the foregoing resolution
          to authorize the increase the authorized Common Stock of the
          Company from 100,000,000 shares, par value $0.001 per share,
          to 200,000,000 shares of Common Stock, $0.001 par value per
          share.

[    ]    The undersigned hereby refuses the written consent or
          revokes such written consent if it has been previously
          granted.  A revocation of a previously granted written
          consent will only be effective if received by the
          Company prior to the date that the Company receives
          written consents in respect of a majority of the issued
          and outstanding shares of the Company's stock.

- -----------------------------------------------------------------




<PAGE> 5


     Please sign exactly as your name appears below.  When shares
are held by joint tenants, both should sign.  When signing as
attorney, executor, administrator, trustee or guardian, please
give full title as such.  If a corporation, please sign in the
full corporate name by President or other authorized officer.  If
a partnership, please sign in the partnership name by authorized
person.

     Dated this _____ day of ______________________, 2000.

Label stating name of stockholder
and number of shares held.


                              _________________________________
                              Signature.

                              _________________________________
                              Signature if held jointly.

        PLEASE SIGN, DATE AND RETURN THIS WRITTEN CONSENT
              PROMPTLY USING THE ENCLOSED ENVELOPE.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission